Cargando…
A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or “wet” form of AMD, no therapy is successful for the non-neovascular or “dry” form. Here we discuss the current knowledge on dry A...
Autores principales: | Handa, James T., Bowes Rickman, Cathy, Dick, Andrew D., Gorin, Michael B., Miller, Joan W., Toth, Cynthia A., Ueffing, Marius, Zarbin, Marco, Farrer, Lindsay A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659646/ https://www.ncbi.nlm.nih.gov/pubmed/31350409 http://dx.doi.org/10.1038/s41467-019-11262-1 |
Ejemplares similares
-
Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
por: Ricci, Federico, et al.
Publicado: (2020) -
Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models
por: Landowski, Michael, et al.
Publicado: (2022) -
Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration
por: Riaz, Moeen, et al.
Publicado: (2017) -
Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry
por: Nguyen, Vuong, et al.
Publicado: (2021) -
CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Zhou, Changyang, et al.
Publicado: (2020)